ArticleClinical kidney journal2026
Sex differences in blood pressure and hypertension through adulthood.
Article in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sex differences in hypertension epidemiology and management are increasingly recognized, yet their variation across the adult life course remains incompletely understood. We examined sex-specific differences in hypertension prevalence, awareness, treatment, and blood pressure (BP) control in a German population. Methods: This cross-sectional analysis included 10 000 participants (51% women; mean age 62 ± 8.5 years) from the Hamburg City Health Study. Hypertension was defined per 2023 European Society of Hypertension guidelines. Awareness, treatment, and BP control were defined based on self-reported diagnosis, current medication use, and treated BP below both thresholds. Age-stratified analyses (45-54, 55-64, and 65-74 years) allowed direct sex comparisons. Differences were assessed using modified Poisson regression adjusted for sociodemographic, comorbidity, and lifestyle factors. Results: Hypertension prevalence was higher in men than women (71% vs. 57%), particularly at 45-54 years [50% vs. 32%; adjusted prevalence ratio (PR) 1.44, 95% confidence interval (CI) 1.27-1.62]. Sex differences progressively attenuated with age (PR 1.23, 95% CI 1.15-1.32 at 55-64 years) and converged at 65-74 years (PR 1.04, 95% CI 0.99-1.08). Findings were consistent in analyses based on self-reported menopausal status. Awareness and treatment were similar between sexes. BP control remained low (∼40%) and declined in women at 65-74 years. Conclusion: Hypertension prevalence was high and BP control suboptimal. Sex differences in hypertension prevalence varied across the adult life course, with higher prevalence among men at younger ages and convergence after age 55, coinciding with menopausal age. These findings support sex-specific, life stage-oriented hypertension screening and management strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.